GLP-1ActiveCloses in 11 months on Apr 1, 2027

Cardiovascular GLP-1 indication approval 2026: Zepbound (tirzepatide)

47%YES chance

Yes

47%

No

53%

Now 47.1%

Resolution

Resolves to the first GLP-1 to win an additional cardiovascular indication from FDA in 2026.

Source: https://www.fda.gov/

Resolves by Apr 8, 2027.

Recent trades

NO@lanepowell16 hours ago
9.5 sh@ 47%5 SP
YES@lanepowell4 days ago
10.6 sh@ 48%5 SP
NO@tatumwalsh6 days ago
9.5 sh@ 47%5 SP
NO@tatumwalsh16 days ago
19.8 sh@ 49%10 SP
NO@tatumwalsh19 days ago
9.6 sh@ 48%5 SP
NO@sashavargas21 days ago
9.7 sh@ 48%5 SP
NO@rowanmonroe26 days ago
9.8 sh@ 49%5 SP

Top holders

YES holders

No holders yet.

NO holders

No holders yet.

News

Refreshed every 6 hours

No news yet. Endcap's news crawler refreshes every 6 hours.

Discussion

Comments (0)

Sign in to add a comment.

Holders only

No comments yet.